Abiopharma

🔍 Harsh Jeffrey Stephen (Executive)

Company: Advantage Solutions Inc. (ADV)

Report Date: 2026-04-29

Detailed Transactions and Holdings:

• Acquired 12,923 shares of Class A Common Stock (Direct)
  Date: 2026-04-29 | Code: A | equity_swap_involved: false | shares_owned_after: 18,703.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 5,538 shares of Performance Restricted Stock Unit (Derivative)
  Date: 2026-04-29 | Code: A | equity_swap_involved: false | shares_owned_after: 5,538.00 | transaction_form_type: 4 | Footnotes: F3, F3, F3

Footnotes:

• F1: Represents an award of restricted stock units (RSUs) that is a contingent right to receive Class A Common Stock upon vesting. The RSUs are scheduled to vest in equal installments on each of the first, second and third anniversaries of the grant date.
• F2: The amount of shares reported herein reflects a 1-for-25 stock split that was effected by the Issuer on March 26, 2026.
• F3: Represents an award of performance restricted stock units (PSUs) that is a contingent right to receive Class A Common Stock upon vesting. Subject to the achievement of certain performance conditions based on Advantage Cash Earnings and Adjusted EBITDA Margin, the PSUs are scheduled to vest on the third anniversary of the grant date and may vest from 0% to 200% of the target number of PSUs reported on this Form 4.